1-12 of 12
Keywords: Adriamycin
Close
Sort by
Journal Articles
Subject Area:
Further Areas
European Urology (1980) 6 (3): 132–136.
Published Online: 11 August 2017
...F. Edsmyr; T. Berlin; J. Boman; M. Duchek; P.L. Esposti; H. Gustafsson; H. Wijkström; L.G. Collste An 80-mg dose of adriamycin was given intravesically once a month to 58 patients with superficial transitional cell tumor of the bladder. Complete cytological remission was achieved in all 11 patients...
Journal Articles
Subject Area:
Further Areas
European Urology (1977) 3 (5): 276–278.
Published Online: 11 August 2017
...EORTC Urological Group B 52 patients with advanced bladder cancer, no longer controlled by conventional therapy,have been treated by combination chemotherapy with Adriamycin and 5-fluorouracil. The objective remission rate has been 40%. The morbidity of the chemotherapy has not been excessive...
Journal Articles
Subject Area:
Further Areas
European Urology (1982) 8 (4): 213–215.
Published Online: 11 August 2017
...S. Eksborg; F. Edsmyr; I. Näslund Patients with superficial bladder tumors, previously resistant to intravesical instillation therapy with adriamycin or untreated have been treated successfully with Adriamycin dissolved in Tween 80 solution. 11 8 2017 1982 Copyright / Drug Dosage...
Journal Articles
Subject Area:
Further Areas
European Urology (1976) 2 (3): 138–141.
Published Online: 11 August 2017
...M. Pavone-Macaluso; EORTC Genito-urinary Tract Co-Operative Group A Single-drug chemotherapy was employed in a multicentric co-operative trial. Adriamycin was given to 18 patients, VM-26 to 30 and Bleomycin to 33. Almost all patients were suffering from a T3 or T4 bladder cancer with known...
Journal Articles
Subject Area:
Further Areas
European Urology (1985) 11 (2): 73–78.
Published Online: 11 August 2017
...B. Llopis; J. Gallego; J.A. Mompó; F. Boronat; J.F. Jiménez A study was performed on 184 patients with superficial bladder cancer (pTa, pT1), 92 with primary and 92 recurrent tumors. After TUR of all visible lesions, endovesical chemotherapy with thiotepa, adriamycin or cisplatinum was started...
Journal Articles
Subject Area:
Further Areas
European Urology (1985) 11 (4): 269–272.
Published Online: 11 August 2017
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Adriamycin Doxorubicin Mitomycin C Instillation therapy Cancer superficial urinary bladder Absorption of cytostatics Eur. Urol. 11: 269-272 (1985) © 1985 S. Karger AG...
Journal Articles
Subject Area:
Further Areas
European Urology (1985) 11 (5): 309–311.
Published Online: 11 August 2017
...Staffan Eksborg; Folke Edsmyr; Irène Andersson The bladder capacities of 7 5 patients with superficial bladder tumors were measured prior to and during monthly intravesical instillation therapy with adriamycin. When taken off therapy, a decrease in bladder capacity of more than 20 % was observed...
Journal Articles
Subject Area:
Further Areas
European Urology (1986) 12 (4): 253–256.
Published Online: 11 August 2017
...B. Llopis; J. Gallego; J.A. Mompó; F. Boronat; M. Alonso; B. Moreno; J.F. Jiménez Of 146 patients with superficial bladder carcinoma, 66 (35 primary and 31 recurrent from failure of thiotepa chemoprophylaxis) relapsed following transurethral resection (TUR) and chemotherapy with adriamycin or cis...
Journal Articles
Subject Area:
Further Areas
European Urology (1984) 10 (5): 289–293.
Published Online: 11 August 2017
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Mitomycin C Carcinoma in situ Topical chemotherapy Late results Adriamycin Clinical...
Journal Articles
Subject Area:
Further Areas
European Urology (1986) 12 (1): 32–37.
Published Online: 11 August 2017
...K. Jauhiainen; M. Sotarauta; J. Permi; O. Alfthan During long periods of buffered instillations of mitomycin C (MMC) and doxorubicin (adriamycin;ADM) on carcinoma in situ (T(IS)), the complete response was 82% for MMC and 80% for ADM. Even the frequency of progression was about the same (20...
Journal Articles
Subject Area:
Further Areas
European Urology (1984) 10 (6): 398–400.
Published Online: 11 August 2017
...Anders Larson; Staffan Eksborg; Åke Fritjofsson 10 patients with frequently recurrent or wide-spread papillary tumors of the urinary bladder were treated by intravesical instillation of adriamycin (50-110 mg) within 3 h of transurethral resection of the tumors. The highest plasma concentration...
Journal Articles